GenScript · 8 hours ago
Chief Strategy Officer (CSO)
GenScript Biotech Corporation is a global biotechnology group committed to making humans and nature healthier through biotechnology. They are seeking a Chief Strategy Officer to lead their global business strategy, focusing on growth, strategic planning, and innovation within the life sciences and biotech industry.
BiotechnologyGeneticsManufacturing
Responsibilities
Lead core competency identification and strategy, translating insights into actions that drive growth, efficiency, and competitive edge
Shape and deliver mid- to long-term strategies that are both visionary and executable, driving sustainable business success
Lead M&A, partnerships, and investments to strengthen core capabilities and accelerate value creation
Drive cross-functional incubation of new business models to build the company’s next growth engine
Qualification
Required
Master's/Ph.D. in biomedical sciences or related fields with solid R&D or strategic leadership experience
Proven expertise in market intelligence, strategic planning, and high-level negotiations
Strong track record in portfolio management and business expansion, preferably with experience in leading multinational life science companies
Demonstrated global presence and leadership, capable of driving alignment across international teams and markets
Exceptional communication and influence skills, with the ability to foster collaboration across departments and geographies
Preferred
Prior CRO/biotech industry experience is highly desirable
Company
GenScript
GenScript USA, Inc. is a leading contract research organization (CRO) specialized in biological research and drug discovery/development
H1B Sponsorship
GenScript has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (38)
2024 (28)
2023 (19)
2022 (11)
2021 (11)
2020 (12)
Funding
Current Stage
Public CompanyTotal Funding
unknown2015-12-31IPO
Recent News
Morningstar.com
2025-11-10
Company data provided by crunchbase